Connect with us

Technology

AI Transformations in the Epedigree Software Market, Projected USD 4.02 Billion Growth (2024-2028) Driven by Rising Demand for Serializability to Combat Counterfeiting – Technavio Report

Published

on

NEW YORK, Aug. 23, 2024 /PRNewswire/ — The global epedigree software market size is estimated to grow by USD 4.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 18.69% during the forecast period. Rising requirements for serializability to tackle counterfeiting is driving market growth, with a trend towards high-tech developments to smarten pharma supply chain. However, huge time and cost requirements for infrastructural implementation poses a challenge. Key market players include Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Epedigree Software Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 18.69%

Market growth 2024-2028

USD 4023.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

16.01

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 37%

Key countries

US, Germany, Japan, France, and China

Key companies profiled

Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc.

Market Driver

The global pharma industry faces a significant challenge with the proliferation of counterfeit drugs, estimated to be worth billions of dollars. This issue persists due to the intricate pharmaceutical supply chain, which lacks adequate quality control. Forgeries, drug redirection, and other related concerns are on the rise, posing a threat to consumer trust and the industry’s integrity. The pharma industry itself suffers from substantial losses due to the counterfeit market. To address these challenges, ePedigree software has emerged as a crucial solution. Serialization enables stakeholders to take a data-driven approach to inventory network trustworthiness and readiness. Advanced technologies like cloud computing, blockchain, and IoT are expected to revolutionize the pharma supply chain, enhancing efficiency and combating counterfeit drugs. The implementation of real-time product tracking and advanced analytics will streamline business procedures and ensure unit-level tracking. Innovations such as RFID technology, barcode scanners, and tag printers will support the adoption of cutting-edge systems across the pharma production and supply chain network. The expansion of cloud-based network capacities will facilitate extended visibility and collaboration between stakeholders. IoT, in conjunction with analytics, can aid in drug processing from manufacturing to distribution, optimizing stock management and reducing costs. The integration of high-tech developments into the pharma supply chain is fueling the growth of the global ePedigree software market. 

The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. This software helps ensure the authenticity of pharmaceutical products by tracking and verifying their pedigree throughout the supply chain. With the rise of contaminated medicine and counterfeit drugs, ePedigree software has become essential for hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and more. Advanced technologies like smart devices, barcodes, cloud computing, and machine learning are driving innovation in the ePedigree software market. Serializability, counterfeiting prevention, and stock management are key features that make ePedigree software an indispensable tool for pharmaceutical businesses. Cloud-based solutions and blockchain technology offer scalability, security, and cost savings, making them popular choices for IT resources in the industry. EPedigree software also offers advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR) to enhance supply chain management and improve patient safety. By reducing wastage of products and improving inventory maintenance, ePedigree software helps pharmaceutical businesses save on healthcare expenditures and improve drug safety. Overall, the ePedigree software market is poised for continued growth as it addresses the critical need for advanced technologies in the pharma supply chain. 

Explore a 360° Analysis of the Market: Unveil the Impact of AI. For complete insights- Request Sample!

Market Challenges

The ePedigree software market faces significant challenges due to the high cost and time requirements for implementation. The process begins with analyzing regulatory environments and organizational capabilities, followed by customizing vendor solutions for compliance. These steps increase the total implementation cost, which includes hardware and software systems. Preparing packaging lines for serialization necessitates substantial investments and a lengthy time frame. Transitioning from lot management to unit-level serialization is complex due to the heterogeneous supply chain systems. Customization for diverse regulatory requirements and organizational settings adds to the implementation cost. For instance, in the US and Europe, different regulatory standards exist, requiring unique implementation approaches. In the US, ePedigree is updated when custody changes, while Europe uses a centralized national database. Delayed regulatory deadlines in various regions further hinder market growth due to the intricate adoption process, extended implementation cycle, and the need to integrate ePedigree software with existing infrastructure across organizations and supply chains.The ePedigree software market is experiencing significant growth due to the increasing demand for advanced technologies in the pharmaceutical industry. Challenges such as machine learning for predictive analysis, virtual reality for training, and inventory management for stock control are being addressed through innovative solutions. Wastage of products and storage of drugs are major concerns, leading to the adoption of cloud-based and on-premises solutions, including blockchain technology. Hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, biotechnology firms, medical devices sector, food and beverage, and cosmetics industries are investing heavily in healthcare IT to ensure drug pedigree, serialization, and patient safety. Advanced technologies like machine learning, Internet of Things, and track-and-trace solutions are revolutionizing supply chain management. Scalability and flexibility are crucial factors in choosing between cloud-based and on-premises solutions. Drug safety, hardware, IT resources, and blockchain are key areas of focus for reducing healthcare expenditures and ensuring drug safety.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This epedigree software market report extensively covers market segmentation by

Deployment 1.1 On-premises1.2 CloudEnd-user 2.1 Large enterprise2.2 Small and medium enterprisesGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa

1.1 On-premises- On-premises deployment of ePedigree software refers to installing and managing the software within an organization’s own infrastructure. This approach offers several advantages, including greater control, security, and customization. In regulated industries like pharmaceuticals, data security and regulatory compliance are top priorities. On-premises deployment enables companies to maintain full control over their data and ensure adherence to regulations. Additionally, on-premises deployment allows for greater flexibility in customization and integration with existing systems. While there are upfront investment and maintenance requirements, the control, security, and customization capabilities make on-premises deployment a preferred choice for many organizations in the global ePedigree software market.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. EPedigree software refers to a system that ensures the authenticity, safety, and traceability of pharmaceutical products throughout the supply chain. This software utilizes various advanced technologies such as smart devices, serializability, barcodes, machine learning, Internet of Things, cloud computing, and advanced analytics. The primary goal is to prevent the circulation of contaminated medicine and counterfeit drugs, thereby enhancing patient safety. The market is expected to grow exponentially as the importance of secure and transparent pharmaceutical supply chains continues to increase. Virtual assistants and blockchain technology are also being integrated into ePedigree software to streamline processes and improve efficiency.

Market Research Overview

The ePedigree software market is a rapidly growing segment in the pharmaceutical industry, focused on ensuring the authenticity and safety of pharmaceutical products. This software plays a crucial role in combating the prevalent issues of contaminated medicine and counterfeit drugs by implementing smart devices, serializability, and advanced technologies such as barcodes, cloud computing, and machine learning. The pharma supply chain benefits significantly from ePedigree solutions through improved stock management, inventory maintenance, and wastage reduction. The market encompasses various sectors, including hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and biotechnology firms in the medical devices sector, food and beverage, and cosmetics industries. EPedigree software solutions offer scalability, flexibility, and cost-effective cloud-based and on-premises options. With the integration of advanced technologies like blockchain, Internet of Things, advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR), ePedigree software is revolutionizing healthcare IT investments and enhancing patient safety and drug safety.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

DeploymentOn-premisesCloudEnd-userLarge EnterpriseSmall And Medium EnterprisesGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-transformations-in-the-epedigree-software-market-projected-usd-4-02-billion-growth-2024-2028-driven-by-rising-demand-for-serializability-to-combat-counterfeiting—technavio-report-302229589.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Marine Biological Laboratory Appoints Nicole A. Theodosiou as Burroughs Wellcome Director of Education

Published

on

By

WOODS HOLE, Mass., July 23, 2026 /PRNewswire/ — The Marine Biological Laboratory (MBL) has appointed Nicole A. Theodosiou, Ph.D., as its next Burroughs Wellcome Director of Education at the Marine Biological Laboratory. She will join the MBL on September 8.

Theodosiou brings more than two decades of experience in science education, academic leadership, and program development. She joins the MBL from Union College in Schenectady, New York, where she held a number of leadership roles focused on curriculum innovation, faculty development, and undergraduate STEM education. Most recently, she served as Special Projects Director for Initiatives in Pedagogy & Course Design. Previously, she directed the Howard Hughes Medical Institute Inclusive Excellence Initiative, led the Biochemistry Program, and served as a faculty member in the Department of Biology.

Throughout her career, Theodosiou has developed interdisciplinary educational programs, led faculty development initiatives, and advanced innovative approaches to teaching and learning. She is a member of the Society for Developmental Biology Academy and served on the Society’s Board of Directors as chair of its Professional Development and Education Committee, where she helped create professional development programs and educational resources for scientists nationwide.

At the MBL, Theodosiou will lead the institution’s educational programs, including its internationally renowned Advanced Research Training Courses (ARTCs), undergraduate and high school programs, and other educational initiatives that support the Laboratory’s mission of advancing biological discovery through research and education.

“Education has been central to the MBL’s mission since our founding in 1888,” said Nipam H. Patel, Director of the MBL. “Nicole brings a remarkable combination of scientific expertise, educational leadership, and strategic vision. Her commitment to experiential learning and developing innovative educational programs makes her an outstanding addition to our leadership team as we work to magnify the MBL’s educational impact for the next generation of scientists. “

Theodosiou has maintained a longstanding connection to the MBL throughout her career. She participated in the Laboratory’s Gene Regulatory Networks course in 2015, collaborated with the Marine Resource Center in support of her research, and has mentored students who have participated in MBL educational programs. She has described the MBL’s educational ecosystem as “unparalleled” and its tradition of learning by doing as closely aligned with her own philosophy of science education.

“The MBL has always been a place where scientific discovery and education go hand in hand,” said Theodosiou. “Its tradition of learning by doing and global community has inspired generations of researchers, including myself. I’m honored to join the MBL community and look forward to strengthening and building on its extraordinary legacy to inspire and train the next generation of scientists. “

Theodosiou earned a Ph.D. in Genetics from Yale University and a bachelor’s degree in biology from Swarthmore College. Her research as a developmental biologist has focused on vertebrate evolution and development, while her educational leadership has emphasized creating accessible, research-driven learning environments that integrate science, education, and communication.

About the Marine Biological Laboratory

The Marine Biological Laboratory (MBL) is dedicated to scientific discovery—exploring fundamental biology, understanding biodiversity and the environment, and informing the human condition through research and education. Founded in Woods Hole, Massachusetts, in 1888, the MBL is a private, nonprofit institution.

Media Contact:
Samantha Cummis
Scummis@mbl.edu
973-800-4118

View original content to download multimedia:https://www.prnewswire.com/news-releases/marine-biological-laboratory-appoints-nicole-a-theodosiou-as-burroughs-wellcome-director-of-education-302833514.html

SOURCE Marine Biological Laboratory

Continue Reading

Technology

Marine Biological Laboratory Appoints Nicole A. Theodosiou as Burroughs Wellcome Director of Education

Published

on

By

WOODS HOLE, Mass., July 23, 2026 /PRNewswire/ — The Marine Biological Laboratory (MBL) has appointed Nicole A. Theodosiou, Ph.D., as its next Burroughs Wellcome Director of Education at the Marine Biological Laboratory. She will join the MBL on September 8.

Theodosiou brings more than two decades of experience in science education, academic leadership, and program development. She joins the MBL from Union College in Schenectady, New York, where she held a number of leadership roles focused on curriculum innovation, faculty development, and undergraduate STEM education. Most recently, she served as Special Projects Director for Initiatives in Pedagogy & Course Design. Previously, she directed the Howard Hughes Medical Institute Inclusive Excellence Initiative, led the Biochemistry Program, and served as a faculty member in the Department of Biology.

Throughout her career, Theodosiou has developed interdisciplinary educational programs, led faculty development initiatives, and advanced innovative approaches to teaching and learning. She is a member of the Society for Developmental Biology Academy and served on the Society’s Board of Directors as chair of its Professional Development and Education Committee, where she helped create professional development programs and educational resources for scientists nationwide.

At the MBL, Theodosiou will lead the institution’s educational programs, including its internationally renowned Advanced Research Training Courses (ARTCs), undergraduate and high school programs, and other educational initiatives that support the Laboratory’s mission of advancing biological discovery through research and education.

“Education has been central to the MBL’s mission since our founding in 1888,” said Nipam H. Patel, Director of the MBL. “Nicole brings a remarkable combination of scientific expertise, educational leadership, and strategic vision. Her commitment to experiential learning and developing innovative educational programs makes her an outstanding addition to our leadership team as we work to magnify the MBL’s educational impact for the next generation of scientists. “

Theodosiou has maintained a longstanding connection to the MBL throughout her career. She participated in the Laboratory’s Gene Regulatory Networks course in 2015, collaborated with the Marine Resource Center in support of her research, and has mentored students who have participated in MBL educational programs. She has described the MBL’s educational ecosystem as “unparalleled” and its tradition of learning by doing as closely aligned with her own philosophy of science education.

“The MBL has always been a place where scientific discovery and education go hand in hand,” said Theodosiou. “Its tradition of learning by doing and global community has inspired generations of researchers, including myself. I’m honored to join the MBL community and look forward to strengthening and building on its extraordinary legacy to inspire and train the next generation of scientists. “

Theodosiou earned a Ph.D. in Genetics from Yale University and a bachelor’s degree in biology from Swarthmore College. Her research as a developmental biologist has focused on vertebrate evolution and development, while her educational leadership has emphasized creating accessible, research-driven learning environments that integrate science, education, and communication.

About the Marine Biological Laboratory

The Marine Biological Laboratory (MBL) is dedicated to scientific discovery—exploring fundamental biology, understanding biodiversity and the environment, and informing the human condition through research and education. Founded in Woods Hole, Massachusetts, in 1888, the MBL is a private, nonprofit institution.

Media Contact:
Samantha Cummis
Scummis@mbl.edu
973-800-4118

View original content to download multimedia:https://www.prnewswire.com/news-releases/marine-biological-laboratory-appoints-nicole-a-theodosiou-as-burroughs-wellcome-director-of-education-302833514.html

SOURCE Marine Biological Laboratory

Continue Reading

Technology

Canada’s investment industry and business community welcome Ontario’s commitment to join regulatory passport system

Published

on

By

Industry, business, and professional associations voice strong support for greater regulatory harmonization and a more competitive Canadian economy

TORONTO, July 23, 2026 /CNW/ — Canada’s investment industry and business community welcome Ontario’s commitment to join the country’s securities regulatory passport system, marking a significant step toward greater regulatory harmonization and a more efficient and competitive Canadian capital market.

A coalition of associations representing firms and professionals from across Canada’s capital markets sector, together with a broad cross-section of the business community, strongly supports the announcement by Ontario Finance Minister Peter Bethlenfalvy at the recent meeting of Canada’s finance ministers, convened by Federal Finance Minister Francois-Philippe Champagne, and supported by their provincial and territorial counterparts.

Ontario’s participation in the passport system will make it easier for firms to operate and raise capital across Canada, while reducing unnecessary regulatory duplication and costs. More broadly, it advances the national effort to remove internal trade barriers, boost productivity and strengthen Canada’s economic competitiveness.

The passport system has already demonstrated that greater regulatory coordination can be achieved while respecting provincial jurisdiction. Participating regulators retain their authority and distinct roles, while firms benefit from a system in which decisions made by a principal regulator are generally recognized across participating jurisdictions.

Ontario’s participation creates an opportunity not only to reduce duplication but also to strengthen the system as a whole. A more integrated model can better leverage the expertise and capabilities of regulators across the country, creating opportunities for greater regulatory specialization and leadership in areas where individual jurisdictions have particular strengths.

For firms, greater harmonization means more predictable regulation, less duplication, and a more efficient regulatory environment. For investors, it supports a framework that maintains strong investor protection while responding more effectively to an increasingly complex and competitive global marketplace. For Canada, it helps create a more attractive environment in which to invest, launch new products and raise capital.

This coalition stands ready to work with governments and securities regulators across Canada to support Ontario’s timely and successful implementation of the passport system and build on the progress already made. We encourage all parties to move quickly to bring Ontario into the existing framework, while preserving the features that have made the passport system work so effectively.

Ontario’s commitment is a milestone and an important step toward a more integrated, efficient and competitive capital market that will strengthen the Canadian economy and better serve Canadian investors and businesses.

About the coalition

The Canadian Bankers Association (CBA) is the voice of more than 60 domestic and foreign banks that help drive Canada’s economic growth and prosperity. The CBA advocates for public policies that contribute to a sound, thriving banking system to ensure Canadians can succeed in their financial goals. 

The Canadian ETF Association (CETFA) is the national voice of Canada’s ETF industry, representing approximately 96 per cent of exchange traded fund (ETF) assets in Canada. CETFA promotes the growth, sustainability and integrity of Canada’s ETF industry. It keeps investment professionals informed about ETF developments, educates investors about ETFs and their benefits, and debunks ETF myths.

CFA Societies Canada is a collaboration of the 12 Canadian CFA Institute member societies, representing over 21,000 CFA charter holders in Canada. Its mission is to lead the investment profession in Canada by advancing the highest professional standards, integrity, and ethics for the ultimate benefit of Canadian society.

Chartered Professional Accountants of Canada (CPA Canada) is one of the most influential accounting organizations in the world. As a non-regulatory body comprised of individual CPA members, CPA Canada supports the profession and represents Canadian CPAs at the national and international levels. Nationally, CPA Canada acts in the public interest to promote transparency in financial markets, prepares CPAs for a rapidly evolving business environment through extensive guidance and programming and contributes to standard setting and policy making. Globally, CPA Canada works together with international bodies to build a stronger accounting profession worldwide. Its dedicated efforts help shape public policy, influence regulatory frameworks and establish high professional standards that reflect the evolving needs of the accounting industry.

The Alternative Investment Management Association (AIMA) is the global representative of the alternative investment industry, with around 2,100 corporate members in over 60 countries. AIMA’s fund manager members collectively manage more than US$4 trillion in hedge fund and private credit assets. AIMA draws upon the expertise and diversity of its membership to provide leadership in industry initiatives such as advocacy, policy and regulatory engagement, educational programs and sound practice guides. AIMA works to raise media and public awareness of the value of the industry. AIMA set up the Alternative Credit Council (ACC) to help firms focused in the private credit and direct lending space. The ACC currently represents over 250 members that manage US$2 trillion of private credit assets globally. AIMA is committed to developing skills and education standards and is a co-founder of the Chartered Alternative Investment Analyst designation (CAIA) – the first and only specialized educational standard for alternative investment specialists. AIMA is governed by its Council (Board of Directors). AIMA was founded in 1990, with the AIMA Canada subsidiary formed in 2003.

The Ontario Chamber of Commerce (OCC) is the indispensable partner of business and Canada’s largest, most influential provincial chamber. It is an independent, non-profit advocacy and member services organization representing a diverse network of 60,000 members. The OCC convenes, mobilizes and empowers business and local chambers in pursuit of its purpose: to bring inclusive and sustainable prosperity to Ontario’s businesses, workers, and communities.

The Pension Investment Association of Canada (PIAC) has been the foremost voice for Canadian pension funds in matters related to pension investment and governance since 1977. PIAC is composed of over 130 of the largest pension plans in the country who manage over $3.5 trillion of assets on behalf of millions of Canadians. Its mission is to promote sound investment practices and good governance for the benefit of plan sponsors and beneficiaries.

The Portfolio Management Association of Canada (PMAC) represents over 300 asset management firms that manage more than $4 trillion in assets. Members are all fiduciaries managing investments in the best interests of their clients, which include private individuals, foundations, universities and pension plans. PMAC employs a collaborative information-sharing business model and advocates on behalf of its members on securities regulation and government policy matters. The association’s mission is to advocate the highest standards of unbiased portfolio management in the interest of investors served by members.

The Securities and Investment Management Association (SIMA) empowers Canada’s investment industry. The association, formerly The Investment Funds Institute of Canada (IFIC), is the leading voice for the securities and investment management industry, which oversees approximately $4.5 trillion in assets for over 20 million investors and the Canadian capital markets. Our members–including investment fund managers, investment and mutual fund dealers, capital markets participants, and professional service providers–are committed to creating a resilient, innovative investment sector that fuels long-term economic growth and creates opportunities for all Canadians.

SOURCE Securities and Investment Management Association

Continue Reading

Trending